VENTURES

Aurum Ventures MKI provides value added growth capital to exceptional entrepreneurs in the healthcare area. While we focus on investing in unique, cutting edge technologies that will mature into successful business companies, our investments reflect our own values, so we prefer investing in companies that, through their sound commercial propositions, also contribute to the well-being of mankind. Our team is comprised of senior and experienced hands-on executives who work actively with the portfolio companies in enhancing their strategic and execution capabilities. We typically take a long-term approach, understanding that ventures in the life sciences and healthcare areas take time to mature and be successful.

 

BEYEONICS

Beyeonics develops next-generation, innovative surgeon-centered visualization technologies that improves the surgeon’s efficiency and substantially enhances patient safety and surgical outcomes. Beyeonics’ first clinically tested system - Clarity™ – has a proven track record of providing surgeons with Augmented/Virtual Reality vision capabilities that replace surgical microscopes while allowing real-time integration of an unlimited amount of data. The Clarity platform is comprised of a Transparent Head Wearable Display that utilizes unique displays technology (originally developed by Elbit Systems for fighter planes), 3D Ultra-Resolution remote sensing cameras, and an ultra-fast Processing Core, as well as fusion and analytical tools to enable zero latency integration of information from multiple digital sources. Undergoing clinical trials since 2016 the Clarity platform has been successfully tested in numerous ophthalmic surgeries both in Israel and in the US.

PolyPid is a clinical stage specialty pharmaceutical company engaged focusing on targeted, localized drug delivery into the body over periods of time ranging from days to several months.

Beta O2 

Beta-O2 develops a bio-artificial pancreas for the cure of Type-1 Diabetes (T1D). The device is an implantable device containing insulin secreting cells.

beta-o2.png

Zebra

Zebra’s mission is to provide radiologists the tools they need to make the next leap in patient care. The demand for medical imaging services is continuously increasing, outpacing the supply of qualified radiologists and stretching them to produce more output, without compromising patient care. Only by adopting new technology that significantly enhances the capabilities of radiologists, can this crisis be mitigated. Zebra is empowering radiologists with its revolutionary AI1 offering which helps health providers manage the ever increasing workload without compromising quality.

Zebra.jpg

Nucleix

Nucleix develops, manufactures and markets innovative non-invasive molecular cancer diagnostic tests. Nucleix highly sensitive and specific tests are based on identification of subtle changes in DNA methylation patterns, and relies on a combination of a new biochemical platform in conjunction with sophisticated algorithms

nucleix.jpg

VBL

VBL is a clinical stage biopharmaceutical company committed to the development of a novel anti-cancer approach. VBL is publically traded at NASDAQ under the ticker symbol: VBLT.

VBL.jpg

Precise

Precise Bio develops in the field of Tissue Engineering combining 2 technology fields; Regenerative medicine technologies and 3D Bio Printing. Its vision is: “Growing live & vital complicated organs for transplant, with 3D technology”. It’s disruptive technology and experienced team aims to achieve a world with no need for organ harvesting, endless waiting lists and immunosuppressive drugs for patients requiring organs to save their life. Precise-Bio will mature the technology and reach manufacturing readiness in order to enable production of a verity of life saving organs.

PreciseBio.jpg

Scopio

Scopio Labs has developed the next generation digital microscopy platform, bringing the lab microscopy and pathology field into the 21st century. Scopio’s microscopes provide whole digital, whole slide, highest resolution, fully connected microscope slide scans, at 10X lower hardware costs.

The Scopio microscope provides very high resolution Whole Slide Images of blood, bone marrow, CSF and tissue pathology; Furthermore, Scopio microscopes can perform automated analyses of digitized slides with computer vision tools and AI, and allow remote experts to access digital slides anytime, anywhere, for review and reporting, thus eliminating the need for specialized staff at smaller clinical sites, and improving efficiency and quality of medical care.

Scopio.jpg

LifeBond

LifeBond is a clinical stage company developing a line of biosurgical products for the prevention of post-surgical leakages and bleedings.  

lifebond.jpg

© Aurum. Design: Issi Dvir